DEPLOYDatabase

Robot model

Toumai

surgicalcommercialby MicroPort MedBot

The Toumai Endoscopic Surgical Robot is MicroPort MedBot's flagship laparoscopic surgical robotics system, featuring remote telesurgery capabilities.

Track Toumai
Manufacturer
MicroPort MedBot
Form factor
surgical
Maturity
commercial
Lifecycle
active
Deployments
8

The verified answer

As of Aug 2026, DEPLOY verifies Toumai, a surgical by MicroPort MedBot (commercial): 8 verified deployments on record. 1 source back the record.

Overview

The Toumai Endoscopic Surgical Robot is MicroPort MedBot's flagship laparoscopic surgical robotics system, featuring remote telesurgery capabilities. It became the world's first surgical robot to receive regulatory approval for commercial remote surgery in April 2025, and has been deployed in nearly 40 countries across six continents.

Toumai has achieved 100+ commercial orders and 80+ installations worldwide, with notable deployments including Cleveland Clinic Abu Dhabi, Gemelli Hospital Italy, and AZ Delta Belgium.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Manufacturer

MicroPort MedBot

Type

Surgical robot

Maturity

Commercially available

Deployments

8 locations

Data & sources

Press releases

1

1 source backing this record.View all →

Pricing

No verified price is on record for Toumai. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (8)

  • Toumai at Sao Paulo, Braziloperational

    Hospital Nove de Julho completed Latin America's first commercial remote human surgery using Toumai

  • Toumai at Bangkok, Thailandoperational

    Rajavithi Hospital, Thailand's top teaching hospital, designated as official national training center for Toumai

  • Toumai at Mumbai, Indiaoperational

    Kokilaben Dhirubhai Ambani Hospital performed 50+ urology procedures and began multi-specialty expansion within first month

  • Toumai at Casablanca, Moroccooperational

    Four installations in Morocco with over 500 surgeries performed

  • Toumai at Luanda, Angolaoperational

    World's first FDA-IDE approved USA-Africa robotic telesurgery performed at Cardeal Dom Alexandre do Nascimento Hospital Complex in Luanda.

  • Toumai at Aalst, Belgiumoperational

    AZ Delta in Belgium completed 100 cases within 10 weeks and performed Europe's first remote surgery using Toumai

  • Toumai at Romeoperational

    Gemelli Hospital in Italy completed over 50 cases using Toumai

  • Toumai at Abu Dhabioperational

    Deployed at Cleveland Clinic Abu Dhabi, one of the Middle East's top-ranked medical centers

Free to use on your site, with a link back to DEPLOY.

Toumai on the deployment map

View the global map

Where Toumai is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Toumai.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. Toumai Surgical Robot Achieves Global Commercialization Milestone with 100 Orders · https://microport.com/news/toumai-surgical-robot-achieves-global-commercialization-milestone-with-100-orders

Common questions

What is Toumai?
The Toumai Endoscopic Surgical Robot is MicroPort MedBot's flagship laparoscopic surgical robotics system, featuring remote telesurgery capabilities. It became the world's first surgical robot to receive regulatory approval for commercial remote surgery in April 2025, and has been deployed in nearly 40 countries across six continents. Toumai has achieved 100+ commercial orders and 80+ installations worldwide, with notable deployments including Cleveland Clinic Abu Dhabi, Gemelli Hospital Italy, and AZ Delta Belgium.
How much does Toumai cost?
Toumai's price is not publicly disclosed. DEPLOY has no verified price on record for Toumai from MicroPort MedBot. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Toumai actually deployed in the real world?
Yes. Toumai is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Toumai?
Toumai is made by MicroPort MedBot, based in Shanghai, China, founded in 2015.
Where is Toumai deployed?
8 verified deployments of Toumai are on the DEPLOY registry, including at Sao Paulo, Brazil, Bangkok, Thailand, Mumbai, India.
Can you buy Toumai?
Toumai is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to Toumai?
On the DEPLOY registry, comparable surgical robots to Toumai include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does Toumai compare to da Vinci (and Ion)?
Toumai and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Toumai has 8 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Toumai a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Toumai ranks in roughly the top 6% of surgical models tracked by the registry.
What is Toumai's maturity stage?
Toumai is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is Toumai safe?
Toumai has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-07-15

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-15

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Toumai.

Recent coverage

Toumai in third-party press

Milestones for China’s medical AI as robot wins EU nod and model tops benchmark - South China Morning Post

Jun 24, 2026

MicroPort MedBot Wins Landmark EU CE Mark for Toumai Remote Surgical Robot - The Globe and Mail

Jun 22, 2026

Brazilian president calls China-developed surgical robot ‘incredible’; device set world record for longest-distance remote surgery in March, company rep tells GT - Global Times

May 21, 2026